Did COVID-19 Affect Outcomes for Inflammatory Rheumatic Disease Patients?
The COVID-19 pandemic does not appear to have significantly affected the disease course of patients with inflammatory rheumatic diseases including axial spondyloarthritis (axSpA), rheumatoid...
Secukinumab Does Not Increase Risk of TB Reactivation in Rheumatic Disease Patients
Human IgG1κ monoclonal antibody secukinumab used to treat patients with psoriatic arthritis (PsA), psoriasis (PsO), and ankylosing spondylitis was not associated with latent tuberculosis...
Rheum Round-up: Rituximab Biosimilar Comparison, Cognitive Behavioral Therapy for OA, and more
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about a rituximab biosimilar, switching from...
Sleep Disturbance, Fatigue, Anxiety/Depression Commonly Reported in PsA Patients
A recent study analyzed the prevalence of and factors associated with sleep disturbances, fatigue, and anxiety/depression among psoriatic arthritis (PsA) patients.
Decreased health-related quality of...
Psoriatic Arthritis Disease Expression May Differ Between Patients of Different Ethnic Backgrounds
A study observed how ethnicity may affect disease expression of psoriatic arthritis (PsA), observing differences between patients of South Asian (SA) versus North European...
Fatigue Significantly Impacts Numerous Aspects of Life in Patients with RA, AxSpA, PsA
Inflammatory arthritis (IA) patients often experience fatigue; 41% to 51% of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) patients suffer from...
Rheum Round-up: Comorbidities in OA, Racial Disparities in TKA Outcomes, and more
Here are the top stories recently covered by DocWire News in the rheumatology section. In this edition, read about the increased risk for comorbidities...
